Na-Li Jia1, Er-Kang Fei, Zheng Ying, Hong-Feng Wang, Guang-Hui Wang. 1. Laboratory of Molecular Neuropathology, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, China.
Abstract
OBJECTIVE: Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is a dominant neurodegenerative disorder caused by an expansion of the polyglutamine (polyQ) tract in MJD-1 gene product, ataxin-3 (AT3). This disease is characterized by the formation of intraneuronal inclusions, but the mechanism underlying their formation is still poorly understood. The present study is to explore the relationship between wild type (WT) AT3 and polyQ expanded AT3. METHODS: Mouse neuroblastoma (N2a) cells or HEK293 cells were co-transfected with WT AT3 and different truncated forms of expanded AT3. The expressions of WT AT3 and the truncated forms of expanded AT3 were detected by Western blotting, and observed by an inverted fluorescent microscope. The interactions between AT3 and different truncated forms of expanded AT3 were detected by immunoprecipitation and GST pull-down assays. RESULTS: Using fluorescent microscope, we observed that the truncated forms of expanded AT3 aggregate in transfected cells, and the full-length WT AT3 is recruited onto the aggregates. However, no aggregates were observed in cells transfected with the truncated forms of WT AT3. Immunoprecipitation and GST pull-down analyses indicate that WT AT3 interacts with the truncated AT3 in a polyQ length-dependent manner. CONCLUSION: WT AT3 deposits in the aggregation that was formed by polyQ expanded AT3, which suggests that the formation of AT3 aggregation may affect the normal function of WT AT3 and increase polyQ protein toxicity in MJD.
OBJECTIVE:Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is a dominant neurodegenerative disorder caused by an expansion of the polyglutamine (polyQ) tract in MJD-1 gene product, ataxin-3 (AT3). This disease is characterized by the formation of intraneuronal inclusions, but the mechanism underlying their formation is still poorly understood. The present study is to explore the relationship between wild type (WT) AT3 and polyQ expanded AT3. METHODS:Mouseneuroblastoma (N2a) cells or HEK293 cells were co-transfected with WT AT3 and different truncated forms of expanded AT3. The expressions of WT AT3 and the truncated forms of expanded AT3 were detected by Western blotting, and observed by an inverted fluorescent microscope. The interactions between AT3 and different truncated forms of expanded AT3 were detected by immunoprecipitation and GST pull-down assays. RESULTS: Using fluorescent microscope, we observed that the truncated forms of expanded AT3 aggregate in transfected cells, and the full-length WT AT3 is recruited onto the aggregates. However, no aggregates were observed in cells transfected with the truncated forms of WT AT3. Immunoprecipitation and GST pull-down analyses indicate that WT AT3 interacts with the truncated AT3 in a polyQ length-dependent manner. CONCLUSION: WT AT3 deposits in the aggregation that was formed by polyQ expanded AT3, which suggests that the formation of AT3 aggregation may affect the normal function of WT AT3 and increase polyQ protein toxicity in MJD.
Authors: G Wang; K Ide; N Nukina; J Goto; Y Ichikawa; K Uchida; T Sakamoto; I Kanazawa Journal: Biochem Biophys Res Commun Date: 1997-04-17 Impact factor: 3.575
Authors: K Nishiyama; S Murayama; J Goto; M Watanabe; H Hashida; S Katayama; Y Nomura; S Nakamura; I Kanazawa Journal: Ann Neurol Date: 1996-11 Impact factor: 10.422
Authors: Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi Journal: Nat Genet Date: 1994-11 Impact factor: 38.330
Authors: Bernd O Evert; Ina R Vogt; Ana M Vieira-Saecker; Lucia Ozimek; Rob A I de Vos; Ewout R P Brunt; Thomas Klockgether; Ullrich Wüllner Journal: J Neuropathol Exp Neurol Date: 2003-10 Impact factor: 3.685
Authors: A Dürr; G Stevanin; G Cancel; C Duyckaerts; N Abbas; O Didierjean; H Chneiweiss; A Benomar; O Lyon-Caen; J Julien; M Serdaru; C Penet; Y Agid; A Brice Journal: Ann Neurol Date: 1996-04 Impact factor: 10.422
Authors: Pawel M Switonski; Agnieszka Fiszer; Katarzyna Kazmierska; Maciej Kurpisz; Wlodzimierz J Krzyzosiak; Maciej Figiel Journal: Neuromolecular Med Date: 2010-10-14 Impact factor: 3.843
Authors: Marcondes C França; Vanessa E Emmel; Anelyssa D'Abreu; Cláudia V Maurer-Morelli; Rodrigo Secolin; Luciana Cardoso Bonadia; Marilza Santos da Silva; Anamarli Nucci; Laura Bannach Jardim; Maria Luiza Saraiva-Pereira; Wilson Marques; Henry Paulson; Iscia Lopes-Cendes Journal: Front Neurol Date: 2012-11-19 Impact factor: 4.003